Physician profile
David E Westberry
NPI 1720049216
$299.41
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.89 · 2020: $88.64 · 2021: $33.53 · 2022: $42.50 · 2023: $17.44 · 2024: $87.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $88.64 | 2020 | |
| Polynovo North America LLC | $46.27 | 2024 | Novosorb Btm |
| Ipsen Biopharmaceuticals, INC | $41.70 | 2019-2022 | |
| Depuy Synthes Sales INC. | $33.53 | 2021 | |
| Molnlycke Health Care US, LLC | $24.71 | 2024 | Mepilex Border Sacrum, Mepilex Border Post-Op Ag, Exufiber Ag+ |
| Pacira Pharmaceuticals Incorporated | $17.60 | 2022 | |
| Cranial Technologies, INC | $17.44 | 2023 | Doc Band |
| Solventum Corporation | $16.43 | 2024 | Prevena |
| Medtronic USA, INC. | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Westberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.